Among these, soluble forms of immune checkpoint molecules—particularly soluble programmed death-ligand 1 (sPD-L1) and soluble programmed death-1 (sPD-1)—have gained attention as potential non-invasive biomarkers in NSCLC. This evidence concerns the gene SPDL1 and non-small cell lung carcinoma.